Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-05-05

FDA Approved: RANOLAZINE — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves Camber Pharmaceuticals' original ANDA for ranolazine, allowing a generic version of the antianginal medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ranolazine (ranolazine)

Snippet

ORIG AP for RANOLAZINE (RANOLAZINE)